Finance

Beta
Lists
XLO:NASDAQ
Xilio Therapeutics Inc
$7.65
-6.82%
(-0.56) 1D
Jun 5, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for XLO...
Open
$8.14
High
$8.26
Low
$7.53
Mkt. cap
45.77M
Avg. vol.
52.52K
Volume
44.50K
52-wk high
$12.74
52-wk low
$6.47
EPS
-$3.51
Beta
-0.10
Shares outstanding
5.98M
No. of employees
76
Open
$8.14
High
$8.26
Low
$7.53
Mkt. cap
45.77M
Avg. vol.
52.52K
Volume
44.50K
52-wk high
$12.74
52-wk low
$6.47
EPS
-$3.51
Beta
-0.10
Shares outstanding
5.98M
No. of employees
76
News stories
From sources across the web
About Xilio Therapeutics Inc
CEO-
Employees76
Founded2016
HeadquartersWaltham, Massachusetts, United States
SectorBiotechnology
Websitexiliotx.com
Last report
May 12, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.58 / -$2.24
+74.11%beat
Revenue / Est. (USD)
12.65M / 8.52M
+48.45%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
8.08M
19.07M
13.69M
12.65M
Cost of goods sold
15.33M
14.32M
-37.92M
-
Cost of revenue
15.33M
14.32M
-37.92M
-
Research and development expenses
-
-
56.04M
19.83M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.12M
6.67M
7.40M
6.93M
Operating expense
7.12M
6.67M
63.44M
26.76M
Total operating expenses
22.45M
21.00M
25.52M
26.76M
Operating income
-14.37M
-1.93M
-11.84M
-14.11M
Other non operating income
-1.48M
-14.36M
24.70M
4.58M
EBT including unusual items
-15.84M
-16.29M
10.36M
-9.53M
EBT excluding unusual items
-15.84M
-16.29M
10.36M
-9.53M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-15.84M
-16.29M
10.36M
-9.53M
Net profit margin
-195.99%
-85.42%
75.70%
-75.34%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-2.50M
-
Net interest expenses
-
-
-2.50M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-13.98M
-1.59M
-11.51M
-13.77M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer